Annals of Oncology Advance Access originally published online on August 8, 2005
Annals of Oncology 2005 16(11):1722; doi:10.1093/annonc/mdi359
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2005 European Society for Medical Oncology
Editorial |
Introducing the BECT (biologically enhanced cytotoxic treatment) concept in cancer treatment
1 Oncology Institute of Southern Switzerland, Radio-Oncology, CH-6504 Bellinzona, Switzerland; 2 Institut Gustave Roussy, Radio-Oncology, Villejuif, France
* E-mail: jacques.bernier@hcuge.ch
| The first 10% of the full text of this article appears below. |
In a recently published paper, Cooper and Ang [1
] proposed the acronym CERT (chemotherapy-enhanced radiation therapy) to describe a regimen in which chemotherapy, delivered concurrently with radiotherapy primarily improves the local or localregional effect(s) of radiotherapy, in contrast with regimens in which chemotherapy primarily seeks to prevent the subsequent appearance of distant metastatic disease.
The